Endocrine oncology

Analysis of immediate 503 thyroid carcinoma deaths: trend of single institution in 2005–2024

Eur Thyroid JPublished Retrospective cohort study

Authors' conclusion

ATC, including anaplastic transformation from PTC and FTC, still accounts for approximately 40% of thyroid cancer deaths after the introduction of systemic drug therapy. Respiratory insufficiency is the most common immediate cause of death.

Study context

Population
Deceased patients treated for thyroid carcinoma (TC) who died from TC, January 2005–June 2024
Participants
503 patients
Exposure
2005–2014 vs 2015–2024
Outcome
Frequency of ATC at diagnosis and of local-related deaths before vs after introduction of lenvatinib
Methodological detailssingle institution
  • Single institution

Main finding

As reported in the abstract

ATC at diagnosis; local-related deaths
  • 2005-2014 vs 2015-2024: P = 0.772
  • 2005-2014 vs 2015-2024: P = 0.736
  • Multivariate logistic regression adjusted for other covariates

Observational data: associations, not effects.

Further findings

Histological types

Anaplastic TC (ATC)
157 (31%)
Papillary TC (PTC)
253 (50%)
Follicular TC (FTC)
67 (13%)
Poorly differentiated TC
17 (3%)
MTC
9 (2%)

Causes of death

Respiratory insufficiency (most common)
192 (38%)
Local-related death
98 (19%)
Brain-related conditions
22 (4%)

Original publication

Analysis of immediate 503 thyroid carcinoma deaths: trend of single institution in 2005–2024. Eur Thyroid J. Published 6 March 2025. doi:10.1530/etj-24-0368

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.